Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections. Can Measurement of Procalcitonin Reduce the Use of Antibiotics?

NCT02171338 is registered in ClinicalTrials.gov with Holbaek Sygehus as lead sponsor.

NCT NCT02171338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02171338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections. Can Measurement of Procalcitonin Reduce the Use of Antibiotics?
Lead sponsor
Holbaek Sygehus
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2013
Completion date
September 30, 2014
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation of chronic obstructive airways disease, pneumonia